Investing.com - IDEXX Labs (NASDAQ:IDXX) reported on Friday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
IDEXX Labs announced earnings per share of $1.04 on revenue of $605.5B. Analysts polled by Investing.com anticipated EPS of $0.9 on revenue of $600.6M. That with comparison to EPS of $0.99 on revenue of $549.39M in the same period a year before. IDEXX Labs had reported EPS of $1.24 on revenue of $605.3M (NYSE:MMM) in the previous quarter. Analysts are expecting EPS of $1.26 and revenue of $633.19M in the upcoming quarter.
IDEXX Labs shares are up 8.65% from the beginning of the year , still down 3.68% from its 52 week high of $294.57 set on October 31, 2019. They are outperforming the S&P 500 which is up 1.18% year to date.
IDEXX Labs follows other major Healthcare sector earnings this month
IDEXX Labs's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar